Selected Publications

For complete list, see my Pubmed or Google Scholar pages

Human-Machine Collaboration

• Long-term Effect of Machine Learning–Triggered Behavioral Nudges on Serious Illness Conversations and End-of-Life Outcomes Among Patients With Cancer, JAMA Oncology (with Chris Manz)

• Effect of Integrating Machine Learning Mortality Estimates With Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients With Cancer, JAMA Oncology (with Chris Manz and Mitesh Patel)

• Validation of a machine learning algorithm to predict 180-day mortality for outpatients with cancer, JAMA Oncology (with Chris Manz & Jinbo Chen)

• Trajectories of mortality risk among patients with cancer and associated end-of-life utilization, npj Digital Medicine (with Manqing Liu & Jinbo Chen)

• Improving Racial Equity in the Veterans Health Administration Care Assessment Needs Risk Score, HSR (with Amol Navathe & Kristin Linn)

• Performance drift in a mortality prediction algorithm among patients with cancer during the SARS-CoV-2 pandemic, JAMIA (with Jinbo Chen & Amol Navathe)

• Oncologist phenotypes and associations with response to a machine learning-based intervention to increase advance care planning: Secondary analysis of a randomized clinical trial, PLOS One (with Eric Li)

• A machine learning approach to identify distinct subgroups of veterans at risk for hospitalization or death using administrative and electronic health record data, PLOS One (with Amol Navathe & Kristin Linn)

• Regulation of predictive analytics in medicine, Science (with Amol Navathe & Ziad Obermeyer)

• Beyond genes and molecules-a precision delivery initiative for precision medicine, NEJM (with Amol Navathe & Sandy Schwartz)

• Integrating predictive analytics into high-value care: the dawn of precision delivery, JAMA (with David Bates & Meetali Kakad)

• Addressing bias in artificial intelligence in health care, JAMA (with Amol Navathe & Steph Teeple)

Cancer Care Delivery

• Association between FDA label restriction and immunotherapy and chemotherapy use in bladder cancer, JAMA (with Ronac Mamtani, Blythe Adamson, & Aaron Cohen)

• Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval, JAMA Oncology (with Ron Mamtani and Rebecca Hubbard)

• Association of utilization management policy with uptake of hypofractionated radiotherapy among patients with early-stage breast cancer, JAMA Oncology (with Justin Bekelman, Atul Gupta, & Gosia Sylwestrzak)

• Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial-Ineligible Patients With Advanced Solid Cancers, JAMA Oncology (with Ron Mamtani, Qi Long, and Rebecca Hubbard)

• Next-Generation Alternative Payment Models in Oncology—Will Precision Preclude Participation?, JAMA Oncology (with Stephen Schleicher & Sam Mullangi)

• Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer, European Urology Oncology (with John Lin and Alicia Morgans)

• Impact of the COVID-19 Pandemic on Treatment Patterns for Patients with Metastatic Solid Cancer in the United States, JNCI (with Sam Takorian, Ron Mamtani, & Rebecca Hubbard)

• Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic Prostate Cancers, JNCCN (with Kara Maxwell and Jeff Shevach)

• Using Big Data and Predictive Analytics to Determine Patient Risk in Oncology, ASCO Educational Book (with Justin Bekelman)

• Digital Health Applications in Oncology: An Opportunity to Seize, JNCI (with the National Cancer Policy Forum)

• The Oncology Care Model at 5 Years—Value-Based Payment in the Precision Medicine Era, JAMA Oncology (with Stephen Schleicher & Sam Mullangi)

• Blood-based screening for colon cancer: a disruptive innovation or simply a disruption?, JAMA (with Vinay Prasad)

• Characteristics of physicians participating in Medicare’s Oncology Care Model bundled payment program, JCO Oncology Practice (with Amol Navathe, Zeke Emanuel, & Justin Bekelman)

• Remote Patient-Reported Outcomes and Activity Monitoring to Improve Patient-Clinician Communication Regarding Symptoms and Functional Status: A Randomized Controlled Trial. JCO Oncology Practice (with Chris Manz)

Advanced Illness

• Early specialty palliative care—translating data in oncology into practice, NEJM (with Jennifer Temel, Tom Smith, & Rebecca Kirch)

• Precision Palliative Care as a Pragmatic Solution for a Care Delivery Problem, Journal of Clinical Oncology (with Ramy Sedhom and Larry Shulman)

• The Serious Illness Care Program: Implementing a Key Element of High-Quality Oncology Care. NEJM Catalyst (with Pallavi Kumar)

• Medicaid Expansion Associated With Increase In Palliative Care For People With Advanced-Stage Cancers. Health Affairs (with Xuesong Han and Robin Yabroff)

• Machine learning approaches to predict 6-month mortality among patients with cancer, JAMA Netw Open (with Chris Manz)

• Development and application of a machine learning approach to assess short-term mortality risk among patients with cancer starting chemotherapy, JAMA Netw Open (with Ziad Obermeyer, Aymen Elfiky, & Max Pany)

• Clinician Perspectives on Virtual Specialty Palliative Care for Patients With Advanced Illnesses, Journal of Palliative Medicine (with Tamar Klaiman, Amol Navathe, and Zeke Emanuel)

• Oncologist Perceptions of Algorithm-Based Nudges to Prompt Early Serious Illness Communication: A Qualitative Study, Journal of Palliative Medicine (with Mitesh Patel, Judy Shea, and Jennifer Temel)

Policy and Advocacy

• Paying for artificial intelligence in medicine, npj Digital Medicine (with Lorens Helmchen)

• Evaluation of spending differences between Medicare Advantage and the Medicare Shared Savings Program, JAMA Netw Open (with Zeke Emanuel and Amol Navathe)

• Trends in Enrollment in Employer-Sponsored Health Insurance in the US Before and During the COVID-19 Pandemic, JAMA Netw Open (with Zeke Emanuel and Amol Navathe)

• The Older Americans Act at 50—community-based care in a value-driven era, NEJM (with Joanne Lynn & Anne Montgomery)

• Getting real about health care costs—a broader approach to cost stewardship in medical education, NEJM (with Sachin Jain & Arnie Milstein)

• Metastasis-free survival in prostate cancer: Faster drug approvals, better drugs?, Journal of Clinical Oncology (with Vinay Prasad)

• Advancing a quality-of-life agenda in cancer advocacy: Beyond the war metaphor, JAMA Oncology (with Otis Brawley & Rebecca Kirch)